BackLiminatus Pharma Warrants Overview

Liminatus Pharma Warrants Long Term Debt

Track Liminatus Pharma Warrants's long-term debt ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$0.00

Peer average / median

Loading

Liminatus Pharma Warrants Long Term Debt History

Loading

Liminatus Pharma Warrants vs. peers: Long Term Debt Comparison

Loading

Liminatus Pharma Warrants Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Liminatus Pharma Warrants (LIMNW) FAQ

Liminatus Pharma Warrants posts a long-term debt of $0 as of March 2022. In the prior-year period, the figure was $0. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Liminatus Pharma Warrants's long-term debt was $0. The latest reading is $0 (period ending March 2022). Use the history and growth charts on this page for a longer lookback.

Long-Term Debt is one piece of Liminatus Pharma Warrants's financial statement story. At $0, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for LIMNW's long-term debt usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Liminatus Pharma Warrants's other metric pages and overview cover the third.